Latanoprost/Timolol Elvim (Timolol Maleate, Latanoprost)

Timolol maleate is a non‑selective beta‑adrenergic blocker that reduces the production of aqueous humor by inhibiting beta‑1 and beta‑2 receptors in the ciliary body, thereby contributing to a decrease in intra‑ocular pressure.

The prescribed dose is determined by the treating ophthalmologist. Typically, one drop is instilled in the affected eye(s) once daily in the evening, but the exact regimen should follow the clinician’s instructions.

Safety in pregnancy and lactation has not been established. The prescriber must weigh potential benefits against possible risks and consider alternative treatments if appropriate.

Enquiries are submitted via the product page on gnhindia.com, where you specify the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

The combination offers complementary mechanisms—Latanoprost increases outflow of aqueous humor while Timolol decreases its production—resulting in a greater overall reduction of intra‑ocular pressure than either agent used separately, often allowing once‑daily dosing.

Store the eye‑drop bottles at room temperature, below 25 °C, in the original packaging. Keep the container tightly closed, protect from light and moisture, and discard any product that appears discolored or contains particles.

The medication is applied as a single drop to each prescribed eye, usually in the evening. Patients should wash their hands before use, avoid touching the tip of the bottle to the eye or any surface, and wait at least five minutes before applying other eye medications.

Serious risks include severe allergic reactions such as angio‑edema, significant cardiac events like chest pain or arrhythmias, bronchospasm in susceptible individuals, and sudden loss of vision. Any of these symptoms require immediate medical attention.

Patients with known hypersensitivity to either component, those with severe asthma, chronic obstructive pulmonary disease, sinus node dysfunction, bradycardia, or uncontrolled heart failure should avoid this medication unless specifically directed by a physician.